Reporting Manager
James N. Topper
Symbol
ERAS
Shares outstanding
282,198,138 shares
Disclosed Ownership
22,575,851 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 09:44:40 UTC
Date of event
31 Mar 2025
Next filing
14 Aug 2025

Sponsored

Quoteable Key Fact

"Frazier Life Sciences Public Fund, L.P. disclosed 8% ownership in Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS) on 31 Mar 2025."

Quick Takeaways

  • Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Erasca, Inc. Common Stock, $0.0001 par value per share (ERAS).
  • Disclosed ownership: 8%.
  • Date of event: 31 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2025, 09:44.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (17)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Frazier Life Sciences Public Fund, L.P. 5.3% 14,929,001 0 14,929,001 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P.
FHMLSP, L.P. 5.3% 14,929,001 0 14,929,001 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P.
FHMLSP, L.L.C. 5.3% 14,929,001 0 14,929,001 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP, L.L.C.
Frazier Life Sciences Public Overage Fund, L.P. 0.8% 2,373,243 0 2,373,243 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P.
FHMLSP Overage, L.P. 0.8% 2,373,243 0 2,373,243 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P.
FHMLSP Overage, L.L.C. 0.8% 2,373,243 0 2,373,243 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C.
Frazier Life Sciences X, L.P. 0.6% 1,670,580 0 1,670,580 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P.
FHMLS X, L.P. 0.6% 1,670,580 0 1,670,580 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P.
FHMLS X, L.L.C. 0.6% 1,670,580 0 1,670,580 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS X, L.L.C.
Frazier Life Sciences XI, L.P. 1.3% 3,603,027 0 3,603,027 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P.
FHMLS XI, L.P. 1.3% 3,603,027 0 3,603,027 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P.
FHMLS XI, L.L.C. 1.3% 3,603,027 0 3,603,027 /s/ Steve R. Bailey By Steve R. Bailey, CFO of FHMLS XI, L.L.C.
James N. Topper 8% 22,575,851 0 22,575,851 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Patrick J. Heron 8% 22,575,851 0 22,575,851 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017
Albert Cha 6.1% 17,302,244 0 17,302,244 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
James Brush 6.1% 17,302,244 0 17,302,244 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021
Daniel Estes 1.3% 3,603,027 0 3,603,027 /s/ Steve R. Bailey By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022